210 related articles for article (PubMed ID: 21497449)
1. Expression of the insulin-like growth factor-II mRNA-binding protein 3 (IMP3) and carcinoembryonic antigen (CEA) in mucinous minimal deviation adenocarcinoma.
He Y; Li L; Jiang W; Wang DQ; Xu L; Huang Q; Zhang Y; Yang KX
Pathol Res Pract; 2011 May; 207(5):295-9. PubMed ID: 21497449
[TBL] [Abstract][Full Text] [Related]
2. IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression.
Li C; Rock KL; Woda BA; Jiang Z; Fraire AE; Dresser K
Mod Pathol; 2007 Feb; 20(2):242-7. PubMed ID: 17192788
[TBL] [Abstract][Full Text] [Related]
3. The utility of PAX8 and IMP3 immunohistochemical stains in the differential diagnosis of benign, premalignant, and malignant endocervical glandular lesions.
Danialan R; Assaad M; Burghardt J; Newcomb P; Cartun RW; Mandavilli S
Gynecol Oncol; 2013 Aug; 130(2):383-8. PubMed ID: 23618832
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia.
Nishio S; Tsuda H; Fujiyoshi N; Ota S; Ushijima K; Sasajima Y; Kasamatsu T; Kamura T; Matsubara O
Pathol Res Pract; 2009; 205(5):331-7. PubMed ID: 19167836
[TBL] [Abstract][Full Text] [Related]
5. Lobular endocervical glandular hyperplasia might become a precursor of adenocarcinoma with pyloric gland features.
Ohta Y; Suzuki T; Hamatani S; Shiokawa A; Kushima M; Ota H
Pathol Res Pract; 2008; 204(9):683-7. PubMed ID: 18462891
[TBL] [Abstract][Full Text] [Related]
6. Gastric gland mucin-specific O-glycan expression decreases as tumor cells progress from lobular endocervical gland hyperplasia to cervical mucinous carcinoma, gastric type.
Yamanoi K; Ishii K; Tsukamoto M; Asaka S; Nakayama J
Virchows Arch; 2018 Sep; 473(3):305-311. PubMed ID: 29845361
[TBL] [Abstract][Full Text] [Related]
7. Preoperative differential diagnosis of minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia of the uterine cervix: a multicenter study of clinicopathology and magnetic resonance imaging findings.
Takatsu A; Shiozawa T; Miyamoto T; Kurosawa K; Kashima H; Yamada T; Kaku T; Mikami Y; Kiyokawa T; Tsuda H; Ishii K; Togashi K; Koyama T; Fujinaga Y; Kadoya M; Hashi A; Susumu N; Konishi I
Int J Gynecol Cancer; 2011 Oct; 21(7):1287-96. PubMed ID: 21685796
[TBL] [Abstract][Full Text] [Related]
8. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
[TBL] [Abstract][Full Text] [Related]
9. Case of minimal deviation adenocarcinoma: possible clinical link to lobular endocervical glandular hyperplasia as its origin.
Sugihara T; Nakagawa S; Sasajima Y; Matsumoto Y; Takeshita S; Ayabe T
J Obstet Gynaecol Res; 2015 Mar; 41(3):483-7. PubMed ID: 25257165
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm.
Morimatsu K; Aishima S; Yamamoto H; Hayashi A; Nakata K; Oda Y; Shindo K; Fujino M; Tanaka M; Oda Y
Hum Pathol; 2013 Sep; 44(9):1714-21. PubMed ID: 23597774
[TBL] [Abstract][Full Text] [Related]
11. [Synchronous mucinous metaplasia and neoplasia of the female genital tract].
Gu WY; Tao X; Zhang LL; Wang L; Zhou XR; Ning Y
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):845-850. PubMed ID: 30423608
[No Abstract] [Full Text] [Related]
12. Clonality analysis suggests that STK11 gene mutations are involved in progression of lobular endocervical glandular hyperplasia (LEGH) to minimal deviation adenocarcinoma (MDA).
Takatsu A; Miyamoto T; Fuseya C; Suzuki A; Kashima H; Horiuchi A; Ishii K; Shiozawa T
Virchows Arch; 2013 Jun; 462(6):645-51. PubMed ID: 23645358
[TBL] [Abstract][Full Text] [Related]
13. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.
Liang J; Mittal KR; Wei JJ; Yee H; Chiriboga L; Shukla P
Int J Gynecol Pathol; 2007 Jan; 26(1):71-5. PubMed ID: 17197900
[TBL] [Abstract][Full Text] [Related]
14. Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and 'adenoma malignum' based on common histopathological criteria.
Tsuda H; Mikami Y; Kaku T; Hasegawa T; Akiyama F; Ohishi Y; Sasajima Y; Kasamatsu T
Pathol Int; 2005 Jul; 55(7):412-8. PubMed ID: 15982216
[TBL] [Abstract][Full Text] [Related]
15. Intranuclear cytoplasmic inclusion is a significant diagnostic feature for the differentiation of lobular endocervical glandular hyperplasia from minimal deviation adenocarcinoma of the cervix.
Hashi A; Yuminamochi T; Xu JY; Kondo T; Katoh R; Hoshi K
Diagn Cytopathol; 2008 Aug; 36(8):535-44. PubMed ID: 18618730
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
Cina SJ; Richardson MS; Austin RM; Kurman RJ
Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
[TBL] [Abstract][Full Text] [Related]
17. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
[TBL] [Abstract][Full Text] [Related]
18. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
19. Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study.
Kawauchi S; Kusuda T; Liu XP; Suehiro Y; Kaku T; Mikami Y; Takeshita M; Nakao M; Chochi Y; Sasaki K
Am J Surg Pathol; 2008 Dec; 32(12):1807-15. PubMed ID: 18779726
[TBL] [Abstract][Full Text] [Related]
20. Forkhead box protein P1 is a useful marker for the diagnosis of mucinous minimal deviation adenocarcinoma of uterine cervix.
Yang Q; Jiang W; Li L; Huang Q; Yang KX
Ann Diagn Pathol; 2014 Aug; 18(4):232-7. PubMed ID: 24908370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
